Hepatology · 2013 · 47 citations · 18 references
Endogenous HBV-CpG ODNs from the HBV genome induce IFN-α production so that nanoparticle-encapsulated HBV-CpG may act as an HBsAg vaccine adjuvant and may also represent a potent therapeutic agent for the treatment of chronic HBV infection.
18
TLR9 signals after translocating from the ER to CpG DNA in the lysosome
Eicke Latz, Annett Schoenemeyer, Alberto Visintin et al. · Nature Immunology · 2004 · 1.3K citations